Anbio Biotechnology: xbrl:AccountsPayableOtherCurrent
| Value | {"amount": 34942, "currency": "USD"} |
|---|---|
| Period | (as of 2023-12-31) |
| Status | current |
| Entity | Anbio Biotechnology |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T19:02:33.643442+02:00
Raw response sha256:
Cite as: FACTANKER, https://factanker.com/fact/82b5adf7-35ba-4c09-a517-fae92ace7c9e
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001213900-25-035802Retrieved: 2026-08-19T19:02:33.643442+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Cite as: FACTANKER, https://factanker.com/fact/82b5adf7-35ba-4c09-a517-fae92ace7c9e
History
- no predecessors — first report